Compare · IINN vs MDLN
IINN vs MDLN
Side-by-side comparison of Inspira Technologies Oxy B.H.N. Ltd. (IINN) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both IINN and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $46.86B, about 2807.7x IINN ($16.7M).
- Over the past year, IINN is down 68.0% and MDLN is down 12.5% - MDLN leads by 55.4 points.
- MDLN has been more active in the news (12 items in the past 4 weeks vs 8 for IINN).
- MDLN has more recent analyst coverage (25 ratings vs 2 for IINN).
- Company
- Inspira Technologies Oxy B.H.N. Ltd.
- Medline Inc.
- Price
- $0.38+0.51%
- $35.64+2.77%
- Market cap
- $16.7M
- $46.86B
- 1M return
- -34.36%
- -10.28%
- 1Y return
- -67.98%
- -12.54%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2025
- News (4w)
- 8
- 12
- Recent ratings
- 2
- 25
Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
Latest IINN
- SEC Form 424B5 filed by Inspira Technologies Oxy B.H.N. Ltd.
- SEC Form 6-K filed by Inspira Technologies Oxy B.H.N. Ltd.
- QTREX Announces Pricing of a $10 Million Registered Direct Offering of Ordinary Shares
- SEC Form 6-K filed by Inspira Technologies Oxy B.H.N. Ltd.
- QTREX's Patent-Pending Technology Achieves First Direct Conversion of 3D-Printed Insulation into Graphene-Like Carbon to Protect Quantum Processors
- QTREX and U.S. Department of Defense Laboratory Target Q4 2026 to Formalize Joint Quantum Development Program
- SEC Form 6-K filed by Inspira Technologies Oxy B.H.N. Ltd.
- SEC Form EFFECT filed by Inspira Technologies Oxy B.H.N. Ltd.
- QTREX Proprietary Quantum Interconnect Platform Exceeds Performance Requirements Established by Strategic Partners
- SEC Form 6-K filed by Inspira Technologies Oxy B.H.N. Ltd.
Latest MDLN
- SEC Form 4 filed by Chief Executive Officer Boyle James M
- SEC Form 4 filed by Chief Operating Officer Miller Stephen L
- Large owner Gic Private Ltd sold $57,280,000 worth of shares (1,600,000 units at $35.80) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $21,002,305 worth of shares (590,284 units at $35.58) (SEC Form 4)
- Large owner Mozart Holdco, Inc. converted options into 500,000 shares and disposed of 500,000 units of Class B Common Stock, increasing direct ownership by 81,083% to 233,520,656 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $79,971,448 worth of shares (2,248,612 units at $35.56) (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Medline Inc.
- SEC Form 10-Q filed by Medline Inc.